129 related articles for article (PubMed ID: 33858650)
1. Hyperoside ameliorates diabetic nephropathy induced by STZ via targeting the miR-499-5p/APC axis.
Zhou J; Zhang S; Sun X; Lou Y; Bao J; Yu J
J Pharmacol Sci; 2021 May; 146(1):10-20. PubMed ID: 33858650
[TBL] [Abstract][Full Text] [Related]
2. Hyperoside Protects HK-2 Cells Against High Glucose-Induced Apoptosis and Inflammation
Zhou J; Zhang S; Sun X; Lou Y; Yu J
Pathol Oncol Res; 2021; 27():629829. PubMed ID: 34257594
[TBL] [Abstract][Full Text] [Related]
3. β-Amyrin ameliorates diabetic nephropathy in mice and regulates the miR-181b-5p/HMGB2 axis in high glucose-stimulated HK-2 cells.
Xu W; Zhang H; Zhang Q; Xu J
Environ Toxicol; 2022 Mar; 37(3):637-649. PubMed ID: 34894065
[TBL] [Abstract][Full Text] [Related]
4. Hyperoside ameliorates glomerulosclerosis in diabetic nephropathy by downregulating miR-21.
Zhang L; He S; Yang F; Yu H; Xie W; Dai Q; Zhang D; Liu X; Zhou S; Zhang K
Can J Physiol Pharmacol; 2016 Dec; 94(12):1249-1256. PubMed ID: 27704873
[TBL] [Abstract][Full Text] [Related]
5. Triptolide inhibits oxidative stress and inflammation via the microRNA-155-5p/brain-derived neurotrophic factor to reduce podocyte injury in mice with diabetic nephropathy.
Gao J; Liang Z; Zhao F; Liu X; Ma N
Bioengineered; 2022 May; 13(5):12275-12288. PubMed ID: 35603354
[TBL] [Abstract][Full Text] [Related]
6. Exosomal microRNA-16-5p from human urine-derived stem cells ameliorates diabetic nephropathy through protection of podocyte.
Duan YR; Chen BP; Chen F; Yang SX; Zhu CY; Ma YL; Li Y; Shi J
J Cell Mol Med; 2021 Dec; 25(23):10798-10813. PubMed ID: 31568645
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy.
Koga K; Yokoi H; Mori K; Kasahara M; Kuwabara T; Imamaki H; Ishii A; Mori KP; Kato Y; Ohno S; Toda N; Saleem MA; Sugawara A; Nakao K; Yanagita M; Mukoyama M
Diabetologia; 2015 Sep; 58(9):2169-80. PubMed ID: 26063197
[TBL] [Abstract][Full Text] [Related]
8. microRNA-15b-5p shuttled by mesenchymal stem cell-derived extracellular vesicles protects podocytes from diabetic nephropathy via downregulation of VEGF/PDK4 axis.
Zhao T; Jin Q; Kong L; Zhang D; Teng Y; Lin L; Yao X; Jin Y; Li M
J Bioenerg Biomembr; 2022 Feb; 54(1):17-30. PubMed ID: 34806156
[TBL] [Abstract][Full Text] [Related]
9. Circ_WBSCR17 aggravates inflammatory responses and fibrosis by targeting miR-185-5p/SOX6 regulatory axis in high glucose-induced human kidney tubular cells.
Li G; Qin Y; Qin S; Zhou X; Zhao W; Zhang D
Life Sci; 2020 Oct; 259():118269. PubMed ID: 32798559
[TBL] [Abstract][Full Text] [Related]
10. MiR-770-5p facilitates podocyte apoptosis and inflammation in diabetic nephropathy by targeting TIMP3.
Wang L; Li H
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32309847
[TBL] [Abstract][Full Text] [Related]
11. HNRNPA1-mediated exosomal sorting of miR-483-5p out of renal tubular epithelial cells promotes the progression of diabetic nephropathy-induced renal interstitial fibrosis.
Liu D; Liu F; Li Z; Pan S; Xie J; Zhao Z; Liu Z; Zhang J; Liu Z
Cell Death Dis; 2021 Mar; 12(3):255. PubMed ID: 33692334
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-122-5p ameliorates tubular injury in diabetic nephropathy via FIH-1/HIF-1α pathway.
Cheng L; Qiu X; He L; Liu L
Ren Fail; 2022 Dec; 44(1):293-303. PubMed ID: 35166173
[TBL] [Abstract][Full Text] [Related]
13. LncTUG1 ameliorates renal tubular fibrosis in experimental diabetic nephropathy through the miR-145-5p/dual-specificity phosphatase 6 axis.
Wang T; Cui S; Liu X; Han L; Duan X; Feng S; Zhang S; Li G
Ren Fail; 2023 Dec; 45(1):2173950. PubMed ID: 36794657
[TBL] [Abstract][Full Text] [Related]
14. Hyperoside reduces albuminuria in diabetic nephropathy at the early stage through ameliorating renal damage and podocyte injury.
Zhang J; Fu H; Xu Y; Niu Y; An X
J Nat Med; 2016 Oct; 70(4):740-8. PubMed ID: 27255369
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-503 contributes to podocyte injury via targeting E2F3 in diabetic nephropathy.
Zha F; Bai L; Tang B; Li J; Wang Y; Zheng P; Ji T; Bai S
J Cell Biochem; 2019 Aug; 120(8):12574-12581. PubMed ID: 30834596
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of mm9_circ_013935 alleviates renal inflammation and fibrosis in diabetic nephropathy via the miR-153-3p/NFIC axis.
Zhang L; Zhang L; Li S; Zhang Q; Luo Y; Zhang C; Huan Q; Zhang C
Can J Physiol Pharmacol; 2021 Nov; 99(11):1199-1206. PubMed ID: 34197715
[TBL] [Abstract][Full Text] [Related]
17. Hsa_circ_0037128 aggravates high glucose-induced podocytes injury in diabetic nephropathy through mediating miR-31-5p/KLF9.
Fang R; Cao X; Zhu Y; Chen Q
Autoimmunity; 2022 Jun; 55(4):254-263. PubMed ID: 35285770
[TBL] [Abstract][Full Text] [Related]
18. miR-188-3p abolishes germacrone-mediated podocyte protection in a mouse model of diabetic nephropathy in type I diabetes through triggering mitochondrial injury.
Wang Y; Feng F; He W; Sun L; He Q; Jin J
Bioengineered; 2022 Jan; 13(1):774-788. PubMed ID: 34847832
[TBL] [Abstract][Full Text] [Related]
19. Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression.
An X; Zhang L; Yuan Y; Wang B; Yao Q; Li L; Zhang J; He M; Zhang J
Sci Rep; 2017 Jul; 7(1):6413. PubMed ID: 28743882
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of p53/miR-34a/SIRT1 axis ameliorates podocyte injury in diabetic nephropathy.
Liang Y; Liu H; Zhu J; Song N; Lu Z; Fang Y; Teng J; Dai Y; Ding X
Biochem Biophys Res Commun; 2021 Jun; 559():48-55. PubMed ID: 33932899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
